Spotlight Correspondence
Leukemia (2003) 17, 2046–2048. doi:10.1038/sj.leu.2403094
Philadelphia-negative acute lymphoblastic leukemia developing in a CML patient in imatinib mesylate-induced complete cytogenetic remission
S Cherrier-De Wilde1, K Rack2, P Vannuffel2, A Delannoy1 and A Hagemeijer3
- 1Hematology Unit, Hôpital de Jolimont, Haine-Saint-Paul, Belgium
- 2Institute of Pathology and Genetics, Loverval, Belgium
- 3Department of Human Genetics, University of Leuven, Leuven, Belgium
